A protective bivalent vaccine against Rift Valley fever and bluetongue
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A protective bivalent vaccine against Rift Valley fever and bluetongue
Authors
Keywords
-
Journal
npj Vaccines
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-30
DOI
10.1038/s41541-020-00218-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor
- (2019) Alejandro Marín-Lopez et al. Viruses-Basel
- Vector competence is strongly affected by a small deletion or point mutations in bluetongue virus
- (2019) René G. P. van Gennip et al. Parasites & Vectors
- Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara
- (2019) Alejandro Marín-López et al. VACCINE
- Prospects of Next-Generation Vaccines for Bluetongue
- (2019) Piet A. van Rijn Frontiers in Veterinary Science
- CD8 T CELL RESPONSES TO AN IMMUNODOMINANT EPITOPE WITHIN THE NON-STRUCTURAL PROTEIN NS1 PROVIDES WIDE IMMUNOPROTECTION AGAINST BLUETONGUE VIRUS IN IFNAR(-/-) MICE
- (2018) Alejandro Marín-López et al. JOURNAL OF VIROLOGY
- Lesions and Cellular Tropism of Natural Rift Valley Fever Virus Infection in Adult Sheep
- (2018) Lieza Odendaal et al. VETERINARY PATHOLOGY
- Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes
- (2017) Sarah Lumley et al. JOURNAL OF GENERAL VIROLOGY
- Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations
- (2016) Femke Feenstra et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4
- (2016) Alejandro Marín-López et al. International Journal of Biological Sciences
- Development of a sheep challenge model for Rift Valley fever
- (2016) Bonto Faburay et al. VIROLOGY
- Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis
- (2015) Femke Feenstra et al. Parasites & Vectors
- An experimental subunit vaccine based on Bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, guinea pigs and IFNAR(−/−) mice
- (2015) D.M. Legisa et al. VACCINE
- Application of Bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2
- (2015) Femke Feenstra et al. VACCINE
- Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe
- (2015) Karen L. Mansfield et al. VACCINE
- VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(−/−) mice
- (2014) Alejandro Marín-López et al. ANTIVIRAL RESEARCH
- Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge
- (2014) F. Feenstra et al. JOURNAL OF GENERAL VIROLOGY
- A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection
- (2014) J. Garcia-Arriaza et al. JOURNAL OF VIROLOGY
- Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle
- (2014) Jenna Anderson et al. VACCINE
- Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
- (2013) Tamara Kusay Jabbar et al. PLoS One
- Clinical development of Modified Vaccinia virus Ankara vaccines
- (2013) Sarah C. Gilbert VACCINE
- Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
- (2013) George M Warimwe et al. Virology Journal
- A Single Immunization with MVA Expressing GnGc Glycoproteins Promotes Epitope-specific CD8+-T Cell Activation and Protects Immune-competent Mice against a Lethal RVFV Infection
- (2013) Elena López-Gil et al. PLoS Neglected Tropical Diseases
- Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus
- (2012) Eva Calvo-Pinilla et al. PLoS One
- Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis
- (2012) Mark Boyce et al. Virology Journal
- Generation of Replication-Defective Virus-Based Vaccines That Confer Full Protection in Sheep against Virulent Bluetongue Virus Challenge
- (2011) E. Matsuo et al. JOURNAL OF VIROLOGY
- Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen
- (2011) Valentina Franceschi et al. VACCINE
- A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR−/− mice upon lethal virus challenge
- (2011) Hani Boshra et al. VACCINE
- The Pathogenesis of Rift Valley Fever
- (2011) Tetsuro Ikegami et al. Viruses-Basel
- Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass
- (2010) R. Alcock et al. Science Translational Medicine
- Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR−/− mice induced by different DNA vaccination regimens
- (2010) Gema Lorenzo et al. VACCINE
- The Pathology and Pathogenesis of Bluetongue
- (2009) N.J. Maclachlan et al. JOURNAL OF COMPARATIVE PATHOLOGY
- Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor
- (2009) Eva Calvo-Pinilla et al. PLoS One
- Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(−/−) mice against lethal bluetongue infection
- (2009) Eva Calvo-Pinilla et al. VACCINE
- Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep
- (2008) Gema Lorenzo et al. VACCINE
- Potential Vectors of Rift Valley Fever Virus in the Mediterranean Region
- (2008) Sara Moutailler et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Vaccines against bluetongue in Europe
- (2007) Giovanni Savini et al. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now